Noseguard for Prevention of Respiratory Infections in Real-World Use
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorDaewoong Pharmaceutical Co. LTD.
About this trial
This study is a prospective clinical study to evaluate the effectiveness of combined use of two nasal protective medical devices (Noseguard and Noseguard Night) in reducing respiratory infection rates, including COVID-19 and influenza, in real-world conditions.
The study will also assess usability, satisfaction, and safety using electronic patient-reported outcomes (ePRO).
Eligibility criteria
Qualifiers
Adults aged ≥19 years
Able to provide informed consent
Disqualifiers
Hypersensitivity to device components
Current COVID-19 or influenza infection
Severe nasal disease
Pregnant or breastfeeding women
Trial design
Treatments tested in this trial
- Noseguard and Noseguard Night
Treatment groups
2,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov